NEW YORK (GenomeWeb News) - Decode Genetics today said second-quarter revenues fell by 27 percent as R&D spending grew 10 percent and losses fell 11 percent.
 
Total receipts for the three months ended June 30 fell to $7.6 million from $10.4 million year over year. The company attributed the decrease in revenue to the conclusion of its diagnostics partnership with Roche in 2006.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.